Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

Clinical trial NCT01826487 · COMPLETED

Trial details

NCT number: NCT01826487
Sponsor: PTC Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophy, Duchenne Muscular Dystrophies Muscular Disorders, Atrophic Muscular Diseases Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases Genetic Diseases, X-Linked Genetic Diseases, Inborn

Start date: 2013-03-26
Primary completion: 2015-08-20
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.